Skip to content

Clinical trials

Leukemia, B-Cell trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, B-Cell Country / region: Czechia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20121
20161
20171
20191
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Terminated3
Active, not recruiting2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
Acerta Pharma BV1
Affimed GmbH1
Loxo Oncology, Inc.1
Merck Sharp & Dohme LLC1
Pharmacyclics Switzerland GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, B-Cell10
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, B-Cell3
Lymphoma, Non-Hodgkin3
Leukemia, Lymphoid2
Neoplasms2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Graft vs Host Disease1
Hematologic Diseases1
Hematologic Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.